Tafluprost
Back to searchMolecule Structure
Scientific Name
Tafluprost
Description of the Drug
Tafluprost is an ophthalmic prostaglandin analog used to lower intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08819
http://www.drugbank.ca/drugs/DB08819
Brand Name(s)
Saflutan, Zioptan
Company Owner(s)
Sandoz Inc, Thea Pharma Inc, Micro Labs Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid FP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1987 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1286148 | |
| Human Metabolome Database | HMDB0015704 | |
| DrugBank | DB08819 | |
| PubChem: Thomson Pharma | 16479496 | 14833400 |
| PubChem | 9868491 | |
| Nikkaji | J1.975.790K | |
| DrugCentral | 4229 | |
| ChemicalBook | CB3401660 | |
| Guide to Pharmacology | 7451 | |
| rxnorm | TAFLUPROST | ZIOPTAN |
| PubChem: Drugs of the Future | 22395198 | |
| ChEBI | 66899 | |
| ZINC | ZINC000013912394 |
